Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nimenrix vs Mencevax in children aged 2 to 10 years
NCT00514904Phase 3Completed
- Sponsor
- GSK
- Start
- Sep 2007
- Primary completion
- Sep 2008
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 4
01
Overview
A Phase 3 trial of meningococcal group A, C, W135 and Y conjugate vaccine in meningococcal disease, sponsored by GSK. Started Sep 2007; status: completed.
02
Drugs
meningococcal group A, C, W135 and Y conjugate vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on NCT00514904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00514904.